We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : Jul 2021
  • Code : CMI4548
  • Pages : 166
  • Formats :
      Excel/PDF
  • Industry : Pharmaceutical

Fungal otitis externa is an infection of the outer ear canal. Fungal otitis externa mostly affects people who live in warm or tropical areas. It also often affects people who swim frequently, live with diabetes, or have other chronic medical and skin conditions. The Symptoms of otitis externa include ear pain, itchiness in the ear canal, a discharge of liquid or pus from the ear and some degree of temporary hearing loss. Otitis externa is relatively common. It's estimated that around 1 in 10 people will be affected by it at some point in their lives.

Market Dynamics

Robust product pipeline for the treatment of fungal otitis externa which are expected to launch during the forecast period is anticipated to drive the growth of the global fungal otitis externa market. For instance, on July 8, 2020, Hill Dermaceuticals, Inc., a U.S.-based pharmaceutical company, initiated a phase II/III Study of the efficacy and safety of miconazole oil versus vehicle oil in the treatment of otomycosis, followed by an open-label safety evaluation. The study is estimated to be completed by December 2021. Furthermore, increasing prevalence of fungal otitis externa is expected to lead to high demand for various treatment therapy. For instance, according to the Sandoz, a subsidiary of Novartis AG, over 80% of the U.S. children experience at least one ear infection by their third birthday. Moreover, according to the American Academy of Family Physicians, the Fungi are identified in about 10% of cases of otitis externa. The most common pathogen is Aspergillus (80 to 90% of cases), followed by Candida.

Key features of the study:

  • This report provides in-depth analysis of the global fungal otitis externa market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global fungal otitis externa market based on the following parameters – Company Highlights, Product Portfolio, Key Highlights, Financial Performance, Market Strategies
  • Key companies covered as a part of this study include Novartis,  Bayer AG,  Sanofi,  GlaxoSmithKline plc.,  AbbVie,  Par Pharmaceutical, Inc.,  Hi-Tech Pharma,  Actavis Mid-Atlantic,  Hill Dermaceuticals Inc,  NuLife Pharmaceuticals,  Glenmark Pharmaceuticals Limited,  Pfizer Inc.,   Janssen Pharmaceutical,  McNeil Consumer Healthcare,  Mylan N.V.,  and Salvat Laboratories
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global fungal otitis externa market  report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fungal otitis externa market

Detailed Segmentation:

  • Global Fungal Otitis Externa Market, By Drug Type:
    • Ear Drops
      • Clotrimazole
      • Fluconazole
      • Acetic Acid (2%)
    • Oral Medications
      • Itraconazole
      • NSAIDS
    • Topical Medications
    • Late Stage Pipeline Drugs
  • Global Fungal Otitis Externa Market, By Fungus Type:
    • Aspergillus
    • Candida
  • Global Fungal Otitis Externa Market, By Route of Administration:
    • Otic
    • Oral
    • Topical
  • Global Fungal Otitis Externa Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Fungal Otitis Externa Market, By Region:
    • North America
      • By Drug Type:
        • Ear Drops
          • Clotrimazole
          • Fluconazole
          • Acetic Acid (2%)
        • Oral Medications
          • Itraconazole
          • NSAIDS
        • Topical Medications
        • Late Stage Pipeline Drugs
      • By Fungus Type:
        • Aspergillus
        • Candida
      • By Route of Administration:
        • Otic
        • Oral
        • Topical
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Drug Type:
        • Ear Drops
          • Clotrimazole
          • Fluconazole
          • Acetic Acid (2%)
        • Oral Medications
          • Itraconazole
          • NSAIDS
        • Topical Medications
        • Late Stage Pipeline Drugs
      • By Fungus Type:
        • Aspergillus
        • Candida
      • By Route of Administration:
        • Otic
        • Oral
        • Topical
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Drug Type:
        • Ear Drops
          • Clotrimazole
          • Fluconazole
          • Acetic Acid (2%)
        • Oral Medications
          • Itraconazole
          • NSAIDS
        • Topical Medications
        • Late Stage Pipeline Drugs
      • By Fungus Type:
        • Aspergillus
        • Candida
      • By Route of Administration:
        • Otic
        • Oral
        • Topical
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Drug Type:
        • Ear Drops
          • Clotrimazole
          • Fluconazole
          • Acetic Acid (2%)
        • Oral Medications
          • Itraconazole
          • NSAIDS
        • Topical Medications
        • Late Stage Pipeline Drugs
      • By Fungus Type:
        • Aspergillus
        • Candida
      • By Route of Administration:
        • Otic
        • Oral
        • Topical
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Drug Type:
        • Ear Drops
          • Clotrimazole
          • Fluconazole
          • Acetic Acid (2%)
        • Oral Medications
          • Itraconazole
          • NSAIDS
        • Topical Medications
        • Late Stage Pipeline Drugs
      • By Fungus Type:
        • Aspergillus
        • Candida
      • By Route of Administration:
        • Otic
        • Oral
        • Topical
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Drug Type:
        • Ear Drops
          • Clotrimazole
          • Fluconazole
          • Acetic Acid (2%)
        • Oral Medications
          • Itraconazole
          • NSAIDS
        • Topical Medications
        • Late Stage Pipeline Drugs
      • By Fungus Type:
        • Aspergillus
        • Candida
      • By Route of Administration:
        • Otic
        • Oral
        • Topical
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
      • Novartis
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Bayer AG
      • Sanofi
      • GlaxoSmithKline plc
      • AbbVie
      • Par Pharmaceutical, Inc
      • Hi-Tech Pharma
      • Actavis Mid-Atlantic
      • Hill Dermaceuticals Inc
      • NuLife Pharmaceuticals
      • Glenmark Pharmaceuticals Limited
      • Pfizer Inc
      • Janssen Pharmaceutical
      • McNeil Consumer Healthcare
      • Mylan N.V.
      • Salvat Laboratories

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug Type
      • Market Snapshot, By Fungus Type
      • Market Snapshot, By Route of Administration
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • PEST Analysis
    • Industry Trends
    • Pipeline Analysis
    • Regulatory Scenario
    • Reimbursement Scenario
    • Epidemiology
    • Drug Price List
    • Treatment Algorithm
    • Physicians Preferences and Views
    • Global Supply Chain Analysis
    • U.S. Total Diagnosed Patients With Fungal Otitis Externa, By Age Group
    • U.S. Patient Rate Of Fungal Otitis Externa, By Season
    • SVT-15652 Market Value & Volume Forecast- Global
    • Insights and Methodology
  4. Global Fungal Otitis Externa Market - Impact of Coronavirus (Covid-19) Pandemic
    • COVID-19 Epidemiology
    • Impact of Covid-19 on the Healthcare Sector
    • Impact of COVID-19 on Clinical Trials and Drug Development
  5. Global Fungal Otitis Externa Market, By Drug Type, 2017 – 2028, (US$ Million) and Volume (No. of Units)
    • Overview
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Ear Drops
      • Overview
        • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million) and Volume (No. of Units)
        • Clotrimazole
        • Fluconazole
        • Acetic Acid (2%)
    • Oral Medications
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million) and Volume (No. of Units)
        • Itraconazole
        • NSAIDS
    • Topical Medications
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million) and Volume (No. of Units)
    • Late Stage Pipeline Drugs
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million) and Volume (No. of Units)
  6. Global Fungal Otitis Externa Market, By Fungus Type, 2017 – 2028, (US$ Mn)
    • Overview
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Aspergillus
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
    • Candida       
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
  7. Global Fungal Otitis Externa Market, By Route of Administration, 2017 – 2028, (US$ Mn)
    • Overview
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Otic
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
    • Oral
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
    • Topical
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
  8. Global Fungal Otitis Externa Market, By Distribution Channel, 2017 – 2028, (US$ Mn)
    • Overview
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2017 – 2028
      • Segment Trends
    • Hospital Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
    • Retail Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
    • Online Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Million)
  9. Global Fungal Otitis Externa Market, By Region, 2017 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, For Regions, 2018–2028
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Million) and Volume (No. of Units)
      • Market Size and Forecast, and Y-o-Y Growth, By Fungus Type, 2017 - 2028, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2028, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Million) and Volume (No. of Units)
      • Market Size and Forecast, and Y-o-Y Growth, By Fungus Type, 2017 - 2028, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2028, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Million) and Volume (No. of Units)
      • Market Size and Forecast, and Y-o-Y Growth, By Fungus Type, 2017 - 2028, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2028, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Million)
        • UK
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Million) and Volume (No. of Units)
      • Market Size and Forecast, and Y-o-Y Growth, By Fungus Type, 2017 - 2028, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2028, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Million)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Million) and Volume (No. of Units)
      • Market Size and Forecast, and Y-o-Y Growth, By Fungus Type, 2017 - 2028, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2028, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Million) and Volume (No. of Units)
      • Market Size and Forecast, and Y-o-Y Growth, By Fungus Type, 2017 - 2028, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2028, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2028, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
  10. Competitive Landscape
      • Novartis
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Bayer AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Sanofi
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • GlaxoSmithKline plc
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • AbbVie
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Par Pharmaceutical, Inc
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Hi-Tech Pharma
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Actavis Mid-Atlantic
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Hill Dermaceuticals Inc
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • NuLife Pharmaceuticals
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Glenmark Pharmaceuticals Limited
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Pfizer Inc
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Janssen Pharmaceutical
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • McNeil Consumer Healthcare
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Mylan N.V.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Salvat Laboratories
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
  11. Section
    • Research Methodology
    • About Us

*Browse 51 market data tables and 36 figures on "Global  Fungal Otitis Externa Market” - Global forecast to 2028

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.